Latest filings (excl ownership)
15-12G
Securities registration termination
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
EFFECT
Notice of effectiveness
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POS AM
Prospectus update (post-effective amendment)
13 Mar 17
POSASR
Automatic shelf registration (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Mar 17
25-NSE
Exchange delisting
1 Mar 17
8-K
Termination of a Material Definitive Agreement
1 Mar 17
8-K
WaferGen Bio-systems Reports Revenue Growth in Fourth Quarter of 2016
15 Feb 17
8-K
WaferGen Bio-systems Announces 1-for-5 Reverse Stock Split
28 Nov 16
8-K
WaferGen Bio-systems Announces Stockholder Approval of Merger with Takara Bio
15 Nov 16
10-Q
2016 Q3
Quarterly report
10 Nov 16
8-K
WaferGen Bio-systems Reports Results for Third Quarter 2016
8 Nov 16
DEFA14A
Additional proxy soliciting materials
8 Nov 16
8-K
WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016
31 Oct 16
DEFA14A
Additional proxy soliciting materials
31 Oct 16
8-K
Results of Operations and Financial Condition
28 Oct 16
DEFA14A
Additional proxy soliciting materials
28 Oct 16
8-K
WaferGen Bio-systems Announces Adjournment of Special Meeting of Stockholders
27 Oct 16
DEFA14A
Additional proxy soliciting materials
27 Oct 16
DEFA14A
Additional proxy soliciting materials
18 Oct 16
UPLOAD
Letter from SEC
20 Sep 16
DEFM14A
Proxy related to merger
15 Sep 16
CORRESP
Correspondence with SEC
13 Sep 16
UPLOAD
Letter from SEC
13 Sep 16
PRER14A
Preliminary revised proxy
30 Aug 16
CORRESP
Correspondence with SEC
29 Aug 16
UPLOAD
Letter from SEC
17 Aug 16
10-Q
2016 Q2
Quarterly report
11 Aug 16
8-K
WaferGen Bio-systems Reports Results for Second Quarter 2016
9 Aug 16
Latest ownership filings
4
JOEL S KANTER
1 Mar 17
4
Michael P Henighan
1 Mar 17
4
Robert Alan Schueren
1 Mar 17
4
R Dean Hautamaki
1 Mar 17
4
IVAN TRIFUNOVICH
1 Mar 17
4
William Douglas McKenzie
1 Mar 17
4
Makoto Kaneshiro
1 Mar 17
4
Rolland Carlson
1 Mar 17
SC 13G/A
WaferGen Bio-systems, Inc.
23 Feb 17
SC 13G/A
WaferGen Bio-systems, Inc.
6 Jan 17
4
JOEL S KANTER
4 Jan 17
4
Robert Alan Schueren
4 Jan 17
4
R Dean Hautamaki
4 Jan 17
4
William Douglas McKenzie
4 Jan 17
4
Makoto Kaneshiro
4 Jan 17
SC 13G
WaferGen Bio-systems, Inc.
28 Nov 16
SC 13G
WaferGen Bio-systems, Inc.
28 Nov 16
SC 13G/A
WaferGen Bio-systems, Inc.
17 Jun 16
SC 13G/A
WaferGen Bio-systems, Inc.
16 Feb 16
SC 13G/A
WaferGen Bio-systems, Inc.
16 Feb 16
SC 13G/A
WaferGen Bio-systems, Inc.
16 Feb 16
SC 13G/A
WaferGen Bio-systems, Inc.
12 Feb 16
SC 13G/A
WaferGen Bio-systems, Inc.
1 Feb 16
4
Michael P Henighan
27 Jan 16
4
IVAN TRIFUNOVICH
26 Jan 16
SC 13G/A
WaferGen Bio-systems, Inc.
19 Jan 16
SC 13G/A
WaferGen Bio-systems, Inc.
11 Jan 16
4
William Douglas McKenzie
5 Jan 16
4
Robert Alan Schueren
5 Jan 16
4
JOEL S KANTER
5 Jan 16
4
Makoto Kaneshiro
5 Jan 16
4
R Dean Hautamaki
5 Jan 16
SC 13G
WaferGen Bio-systems, Inc.
23 Oct 15
4
Rolland Carlson
21 Oct 15
SC 13G
WaferGen Bio-systems, Inc.
21 Oct 15
SC 13G
WaferGen Bio-systems, Inc.
20 Oct 15
SC 13G/A
WaferGen Bio-systems, Inc.
7 Oct 15
4
Change in insider ownership
25 Sep 15
4
Change in insider ownership
24 Sep 15
SC 13G
WaferGen Bio-systems, Inc.
16 Sep 15